Nxera Pharma Co.,Ltd.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.46 USD
−30.77 M USD
183.39 M USD
73.37 M
About Nxera Pharma Co., Ltd.
Sector
Industry
CEO
Chris Cargill
Website
Headquarters
Tokyo
Founded
1990
IPO date
Jul 29, 2004
Identifiers
2
ISIN JP3431300007
Nxera Pharma Co., Ltd. is a technology powered biopharma company focused on specialty medicines in Japan and globally. The company engages in activities from discovery through to late clinical stage and commercialization, internally and in partnership with global pharma and biotech companies. It focuses on some of the fastest-growing areas of medicine across neurology, GI and immunology, metabolic disorders, and rare diseases, and leverages the power of its GPCR targeted structure based drug discovery NxWave platform to provide a source of best- or first-in-class medicines. The company was founded by Shinichi Tamura and Takaya Nakamura on June 22, 1990 and is headquartered in Tokyo, Japan.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SOLTF is 5.44 USD — it has increased by 4.62% in the past 24 hours. Watch Nxera Pharma Co.,Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Nxera Pharma Co.,Ltd. stocks are traded under the ticker SOLTF.
We've gathered analysts' opinions on Nxera Pharma Co.,Ltd. future price: according to them, SOLTF price has a max estimate of 29.14 USD and a min estimate of 6.09 USD. Watch SOLTF chart and read a more detailed Nxera Pharma Co.,Ltd. stock forecast: see what analysts think of Nxera Pharma Co.,Ltd. and suggest that you do with its stocks.
SOLTF reached its all-time high on May 9, 2016 with the price of 237.05 USD, and its all-time low was 4.90 USD and was reached on Dec 26, 2025. View more price dynamics on SOLTF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SOLTF stock is 4.41% volatile and has beta coefficient of 1.29. Track Nxera Pharma Co.,Ltd. stock price on the chart and check out the list of the most volatile stocks — is Nxera Pharma Co.,Ltd. there?
Today Nxera Pharma Co.,Ltd. has the market capitalization of 518.84 M, it has increased by 0.84% over the last week.
Yes, you can track Nxera Pharma Co.,Ltd. financials in yearly and quarterly reports right on TradingView.
Nxera Pharma Co.,Ltd. is going to release the next earnings report on May 8, 2026. Keep track of upcoming events with our Earnings Calendar.
SOLTF net income for the last quarter is −49.27 M USD, while the quarter before that showed −11.30 M USD of net income which accounts for −335.89% change. Track more Nxera Pharma Co.,Ltd. financial stats to get the full picture.
No, SOLTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 374 employees. See our rating of the largest employees — is Nxera Pharma Co.,Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Nxera Pharma Co.,Ltd. EBITDA is −24.94 M USD, and current EBITDA margin is −13.20%. See more stats in Nxera Pharma Co.,Ltd. financial statements.
Like other stocks, SOLTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nxera Pharma Co.,Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nxera Pharma Co.,Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nxera Pharma Co.,Ltd. stock shows the sell signal. See more of Nxera Pharma Co.,Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.